Also trades as: AMYT.L (LSE) · $vol 0M
AMYT NASDAQ
Amryt Pharma plc
1W: +0.0%
1M: +0.7%
3M: +0.2%
1Y: +94.4%
$14.70
Last traded 2023-04-21 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$783M
+46.0% ▲
5Y CAGR: +62.7%
Total Liabilities
$446M
-5.2% ▼
5Y CAGR: +67.4%
Shareholders Equity
$337M
+410.2% ▲
5Y CAGR: +57.6%
Cash & Investments
$113M
-4.9% ▼
5Y CAGR: +66.9%
Total Debt
$199M
+5.7% ▲
Net Debt
$86M
+23.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $25M | $11M | $65M | $119M | $113M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $25M | $11M | $65M | $119M | $113M |
| Net Receivables | $0 | $0 | $36M | $43M | $54M |
| Inventory | $1M | $2M | $44M | $41M | $116M |
| Other Current Assets | $0 | $0 | $2M | $223K | $261K |
| Total Current Assets | $32M | $19M | $147M | $203M | $283M |
| Property, Plant & Equip. | $1M | $1M | $3M | $8M | $7M |
| Goodwill & Intangibles | $63M | $60M | $382M | $324M | $491M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $149K | $2M | $2M | $2M |
| Total Non-Current Assets | $65M | $62M | $387M | $334M | $501M |
| Total Assets | $96M | $81M | $534M | $537M | $783M |
| — Liabilities — | |||||
| Accounts Payable | $12M | $12M | $23M | $90M | $41M |
| Short-Term Debt | $0 | $0 | $0 | $963K | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $77M | $10M | $116M |
| Total Current Liabilities | $12M | $12M | $100M | $101M | $157M |
| Long-Term Debt | $13M | $19M | $178M | $188M | $199M |
| Other Non-Current Liab. | $39M | $47M | $102M | $148M | $72M |
| Total Non-Current Liabilities | $58M | $72M | $305M | $369M | $289M |
| Total Liabilities | $70M | $85M | $405M | $470M | $446M |
| — Equity — | |||||
| Common Stock | $25M | $24M | $12M | $14M | $26M |
| Retained Earnings | -$42M | -$70M | -$134M | -$236M | -$252M |
| Accumulated OCI | $0 | $0 | $249M | $236M | $246M |
| Total Stockholders Equity | $26M | -$4M | $129M | $66M | $337M |
| Total Liabilities & Equity | $96M | $81M | $534M | $537M | $783M |
| — Key Metrics — | |||||
| Total Debt | $13M | $19M | $178M | $188M | $199M |
| Net Debt | -$12M | $8M | $113M | $70M | $86M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |